These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36441658)

  • 61. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
    Dörner T; Posch MG; Li Y; Petricoul O; Cabanski M; Milojevic JM; Kamphausen E; Valentin MA; Simonett C; Mooney L; Hüser A; Gram H; Wagner FD; Oliver SJ
    Ann Rheum Dis; 2019 May; 78(5):641-647. PubMed ID: 30826774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Validation of the ACR-EULAR criteria for primary Sjögren's syndrome in a Dutch prospective diagnostic cohort.
    van Nimwegen JF; van Ginkel MS; Arends S; Haacke EA; van der Vegt B; Sillevis Smitt-Kamminga N; Spijkervet FKL; Kroese FGM; Stel AJ; Brouwer E; Vissink A; Bootsma H
    Rheumatology (Oxford); 2018 May; 57(5):818-825. PubMed ID: 29444331
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and safety of iguratimod on patients with primary Sjögren's syndrome: a randomized, placebo-controlled clinical trial.
    Shao Q; Wang S; Jiang H; Liu L
    Scand J Rheumatol; 2021 Mar; 50(2):143-152. PubMed ID: 33118847
    [No Abstract]   [Full Text] [Related]  

  • 64. Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.
    Capaccio P; Canzi P; Torretta S; Rossi V; Benazzo M; Bossi A; Vitali C; Cavagna L; Pignataro L
    Clin Otolaryngol; 2018 Feb; 43(1):96-102. PubMed ID: 28585263
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome in a Korean cohort.
    Lee J; Koh JH; Kim JW; Sung YK; Lee SS; Choe JY; Shim SC; Kim HS; Kim HR; Kim JM; Kwon SR; Kim HO; Shin K; Lee CH; Chung SH; Kwok SK; Ju JH; Park SH
    Rheumatol Int; 2018 Sep; 38(9):1651-1660. PubMed ID: 30030624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of fatigue and dryness in primary Sjögren's syndrome: Brazilian version of "Profile of Fatigue and Discomfort - Sicca Symptoms Inventory (short form) (PROFAD-SSI-SF)".
    Miyamoto ST; Paganotti MA; Serrano ÉV; Giovelli RA; Valim V
    Rev Bras Reumatol; 2015; 55(2):113-22. PubMed ID: 25582994
    [TBL] [Abstract][Full Text] [Related]  

  • 67. How to assess treatment efficacy in Sjögren's syndrome?
    Vissink A; Bootsma H; Kroese FG; Kallenberg CG
    Curr Opin Rheumatol; 2012 May; 24(3):281-9. PubMed ID: 22450393
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI.
    Heus A; Arends S; Van Nimwegen JF; Stel AJ; Nossent GD; Bootsma H
    Scand J Rheumatol; 2020 Jan; 49(1):38-46. PubMed ID: 31556344
    [No Abstract]   [Full Text] [Related]  

  • 69. Minimal added value of separate dryness assessments compared with overall dryness in ESSPRI in patients with Sjögren's disease.
    de Wolff L; Arends S; Verstappen GM; Bootsma H
    Rheumatology (Oxford); 2024 Feb; 63(2):e29-e31. PubMed ID: 37632773
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.
    Lee SW; Kim BK; Park JY; Kim do Y; Ahn SH; Song J; Park YB; Lee SK; Han KH; Kim SU
    Mod Rheumatol; 2016 Jul; 26(4):576-82. PubMed ID: 26587876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of immunological features with clinical manifestations in primary Sjogren's syndrome: a single-center cross-sectional study.
    Relangi HSK; Naidu GSRSNK; Sharma V; Kumar M; Dhir V; Sharma SK; Sharma A; Minz RW; Jain S
    Clin Exp Med; 2022 Nov; 22(4):613-620. PubMed ID: 34762228
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.
    Newton JL; Frith J; Powell D; Hackett K; Wilton K; Bowman S; Price E; Pease C; Andrews J; Emery P; Hunter J; Gupta M; Vadivelu S; Giles I; Isenberg D; Lanyon P; Jones A; Regan M; Cooper A; Moots R; Sutcliffe N; Bombardieri M; Pitzalis C; McLaren J; Young-Min S; Dasgupta B; Griffiths B; Lendrem D; Mitchell S; Ng WF;
    Ann Rheum Dis; 2012 Dec; 71(12):1973-9. PubMed ID: 22562982
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure.
    Ng WF; Stangroom AJ; Davidson A; Wilton K; Mitchell S; Newton JL
    QJM; 2012 Dec; 105(12):1191-9. PubMed ID: 22976617
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Scoring hypoechogenic areas in one parotid and one submandibular gland increases feasibility of ultrasound in primary Sjögren's syndrome.
    Mossel E; Arends S; van Nimwegen JF; Delli K; Stel AJ; Kroese FGM; Spijkervet FKL; Vissink A; Bootsma H;
    Ann Rheum Dis; 2018 Apr; 77(4):556-562. PubMed ID: 29233833
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
    Liu X; Li X; Li X; Li Z; Zhao D; Liu S; Zhang M; Zhang F; Zhu P; Chen J; Wei W; Lin B; Zhou Y; Chen J; Pang Y; Zhang L; Sun X; Yu Z; Jia Y; Wang J; Sun W; Chiu F; Pang L; Wang G
    Clin Rheumatol; 2019 Mar; 38(3):657-664. PubMed ID: 30280368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study.
    Westhoff G; Dörner T; Zink A
    Rheumatology (Oxford); 2012 Feb; 51(2):262-9. PubMed ID: 21705778
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome.
    Juarez M; Diaz N; Johnston GI; Nayar S; Payne A; Helmer E; Cain D; Williams P; Devauchelle-Pensec V; Fisher BA; Giacomelli R; Gottenberg JE; Guggino G; Kvarnström M; Mariette X; Ng WF; Rosas J; Sánchez Bursón J; Triolo G; Barone F; Bowman SJ
    Rheumatology (Oxford); 2021 Mar; 60(3):1364-1375. PubMed ID: 32949140
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical features and risk factors of neurological involvement in Sjögren's syndrome.
    Ye W; Chen S; Huang X; Qin W; Zhang T; Zhu X; Zhu X; Lin C; Wang X
    BMC Neurosci; 2018 Apr; 19(1):26. PubMed ID: 29703151
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
    Ozek D; Kemer OE; Omma A
    Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
    Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G
    RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.